Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoforce Family compared for treatment of iron deficiency anaemia in Ghanaian patients
PACTR202209576526787Phase 4Recruiting
- Sponsor
- Shalina Healthcare
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial in iron deficiency anemia (IDA) (2 arms), sponsored by Shalina Healthcare. Primary endpoint: Hemoglobin change. Started Dec 2021; status: recruiting.
02
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on PACTR202209576526787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202209576526787.